BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12212509)

  • 1. [Prostate cancer, generalized screening soon?].
    Girault V
    Presse Med; 2002 Aug; 31(26):1205. PubMed ID: 12212509
    [No Abstract]   [Full Text] [Related]  

  • 2. A review of targeted screening for prostate cancer: introducing the IMPACT study.
    Mitra AV; Bancroft EK; Eeles RA;
    BJU Int; 2007 Jun; 99(6):1350-5. PubMed ID: 17419707
    [No Abstract]   [Full Text] [Related]  

  • 3. [What about the contribution of genetics in prostate cancer screening?].
    Nau JY
    Rev Med Suisse; 2014 Jul; 10(437):1474-5. PubMed ID: 25141570
    [No Abstract]   [Full Text] [Related]  

  • 4. Five genetic variants associated with prostate cancer.
    Vickers A; Lilja H; Scardino P
    N Engl J Med; 2008 Jun; 358(25):2740; author reply 2741. PubMed ID: 18572449
    [No Abstract]   [Full Text] [Related]  

  • 5. [Preventing prostate carcinoma in men with familial disposition].
    Paiss T; Gschwend JE; Maier C; Eisele M; Vogel W; Hautmann RE; Herkommer K
    Urologe A; 2002 Nov; 41(6):596-601. PubMed ID: 12524947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors, prevention and early detection of prostate cancer.
    Loeb S; Schaeffer EM
    Prim Care; 2009 Sep; 36(3):603-21. PubMed ID: 19616157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The Campaign Program for Prostate Integrated Research].
    Cussenot O
    Bull Cancer; 2010 Dec; 97(12):1497-8. PubMed ID: 21284142
    [No Abstract]   [Full Text] [Related]  

  • 8. Cancer screening. Genetic analysis points the way to individualized PSA tests.
    Couzin-Frankel J
    Science; 2010 Dec; 330(6011):1602. PubMed ID: 21163976
    [No Abstract]   [Full Text] [Related]  

  • 9. Adding age and genetic risk to PSA test could improve screening for prostate cancer.
    Kmietowicz Z
    BMJ; 2012 Nov; 345():e7467. PubMed ID: 23131672
    [No Abstract]   [Full Text] [Related]  

  • 10. Genetic screening for prostate cancer.
    Harv Mens Health Watch; 2009 Mar; 13(8):6-7. PubMed ID: 19378477
    [No Abstract]   [Full Text] [Related]  

  • 11. What the U.S. Preventive Services Task Force missed in its prostate cancer screening recommendation.
    Catalona WJ; D'Amico AV; Fitzgibbons WF; Kosoko-Lasaki O; Leslie SW; Lynch HT; Moul JW; Rendell MS; Walsh PC
    Ann Intern Med; 2012 Jul; 157(2):137-8. PubMed ID: 22801676
    [No Abstract]   [Full Text] [Related]  

  • 12. Family history and prostate cancer screening with prostate-specific antigen.
    Mäkinen T; Tammela TL; Stenman UH; Määttänen L; Rannikko S; Aro J; Juusela H; Hakama M; Auvinen A
    J Clin Oncol; 2002 Jun; 20(11):2658-63. PubMed ID: 12039927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The case for prostate cancer screening.
    Andriole GL
    Semin Urol; 1993 May; 11(2):50-3. PubMed ID: 7689738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate cancer and prostate specific antigen. A Jamaican perspective.
    Douglas LL
    West Indian Med J; 1999 Jun; 48(2):47-9. PubMed ID: 10492600
    [No Abstract]   [Full Text] [Related]  

  • 15. Prostate-specific antigen testing and prostate cancer screening.
    Djavan B; Eckersberger E; Finkelstein J; Sadri H; Taneja SS; Lepor H
    Prim Care; 2010 Sep; 37(3):441-59, vii. PubMed ID: 20705192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical impact of genetic susceptibility to prostate cancer.
    Bratt O
    Eur Urol; 2014 Sep; 66(3):500-1. PubMed ID: 24702982
    [No Abstract]   [Full Text] [Related]  

  • 17. [Is the prostate cancer screening behaviour of men with familial predisposition predictable?].
    Paiss T; Kahn D; Küfer R; Maier C; Vogel W; Gschwend JE; Hautmann RE; Herkommer K
    Urologe A; 2005 Apr; 44(4):387-92. PubMed ID: 15726312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use and assessment of PSA in prostate cancer.
    Gjertson CK; Albertsen PC
    Med Clin North Am; 2011 Jan; 95(1):191-200. PubMed ID: 21095422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer: current evidence weighs against population screening.
    Boyle P; Brawley OW
    CA Cancer J Clin; 2009; 59(4):220-4. PubMed ID: 19564244
    [No Abstract]   [Full Text] [Related]  

  • 20. Screening for prostate cancer.
    Brawley OW; Ankerst DP; Thompson IM
    CA Cancer J Clin; 2009; 59(4):264-73. PubMed ID: 19564245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.